Stay updated on Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial
Sign up to get notified when there's something new on the Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial page.

Latest updates to the Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No visible changes to page content or layout.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page revision label was updated from v3.4.0 to v3.4.1. This appears to be a minor maintenance update.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check69 days agoChange DetectedLocations section updated: a new 'Locations' header appears with listed US states (Connecticut, District of Columbia, Florida, Massachusetts, New York, Ohio, Pennsylvania, South Carolina, Tennessee, Texas). State-specific subsections were removed, and the record revision updated from v3.3.2 to v3.3.3.SummaryDifference0.9%

- Check91 days agoChange DetectedPublication note now clarifies the automatic PubMed autofill and potential non-relevance to the study, and the page revision label updated to v3.3.2.SummaryDifference0.1%

- Check98 days agoChange DetectedRemoved the notice about a lapse in government funding and NIH operating status. The change does not affect trial details, locations, or results.SummaryDifference0.3%

Stay in the know with updates to Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial page.